Clinical Trials Logo

Solid Malignancies clinical trials

View clinical trials related to Solid Malignancies.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT02537418 Active, not recruiting - Solid Malignancies Clinical Trials

Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens

Start date: October 16, 2015
Phase: Phase 1
Study type: Interventional

The purpose of this study is to find the highest dose of durvalumab or of durvalumab with tremelimumab that can be tolerated without causing very severe side effects when receiving standard chemotherapy and to see what effects the study drugs has on this type of cancer. Patients may receive durvalumab alone or in combination with tremelimumab.

NCT ID: NCT00090727 Active, not recruiting - Clinical trials for Non-Hodgkin's Lymphoma

Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Start date: August 2004
Phase: Phase 1
Study type: Interventional

The purposes of this study are to determine: - the largest dose of AQ4N that can be safely given once a week for three weeks out of a 4 week cycle - the side effects of AQ4N when given on the above schedule - how much AQ4N is in the blood and urine at specific times after administration and how the body get rids of AQ4N - if AQ4N helps treat cancer